Previous 10 | Next 10 |
Invitae (NYSE: NVTA ): Q1 GAAP EPS of -$0.47 in-line. More news on: Invitae Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
SAN FRANCISCO , May 7, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), the leader in advanced medical genetics, today announced financial and operating results for the first quarter ended March 31, 2019 . "We've seen another first quarter of foundational growth ac...
SAN FRANCISCO , May 3, 2019 /PRNewswire/ -- Researchers from Invitae (NYSE: NVTA), a leading genetics company, will present a study of more than 6,500 patients with uterine cancer showing that genetic testing provided more than 80 percent of patients with information ...
Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
Written by Ophir Gottlieb Preface Invitae ( NVTA ) just got a huge boost from mega health insurer UnitedHealthcare, getting chosen as just one of seven labs covered in a new network called Preferred Laboratory Network ((PLN)). Story We are analysts of record making us one ...
SAN FRANCISCO , April 23, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading genetics company, today announced that it will report its first quarter 2019 financial results on Tuesday, May 7, 2019 and will host a conference call and webcast that day at 4:30 p.m. Ea...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. The Bounce/Lag...
Preface In September 2018, I contributed to Vision and Value's blog article GR-MD-02: Keytruda's Partner . A long read, but a very good source of essential research if I do say so myself… More articles have come out since by both Vision and Value and First Genesis Consulting , whi...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...
PASADENA, Calif. , April 11, 2019 /PRNewswire/ -- Today, the FH Foundation announced the launch of the FIND HoFH program to identify individuals at risk for homozygous familial hypercholesterolemia (HoFH). The goal is to accelerate the diagnosis of this life-threatening condition. ...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...